Neuphoria Therapeutics Inc (NEUP)

$5.04 -0.15 (-2.89%)
Market Cap 9.12M
Revenue (ttm) 0.00
Net Income (ttm) -15.49M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 3,400
Avg Vol 49,732
Day's Range N/A - N/A
Shares Out 1.76M
Stochastic %K 26%
Beta 0.25
Analysts Strong Sell
Price Target $19.50

Latest News on NEUP

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Apr 15, 2025, 8:00 AM EDT - 10 days ago

Neuphoria Provides a Review of 2024 and Highlights 2025 Plans

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

Mar 3, 2025, 7:30 AM EST - 7 weeks ago

Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

Feb 12, 2025, 7:00 AM EST - 2 months ago

Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq

Dec 23, 2024, 4:49 PM EST - 4 months ago

Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq